Gabelli & Co Investment Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-831,050	Closed	-$7.46M	–	204
2016 Q3	$7.46M	Buy	+831,050	New	+$5.91M	0.87%	33

Gabelli & Co Investment Advisers's RPTP Position: Q4 2016 in Review

Gabelli & Co Investment Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 831,050 shares — an estimated $7.46M sold.

Gabelli & Co Investment Advisers first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $7.46M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Gabelli & Co Investment Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 831,050 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $7.46M.
Gabelli & Co Investment Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
Gabelli & Co Investment Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $7.46M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2016, filed 10 Feb 2017.